1. Home
  2. OTEX vs ABVX Comparison

OTEX vs ABVX Comparison

Compare OTEX & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

HOLD

Current Price

$30.06

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$116.47

Market Cap

9.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTEX
ABVX
Founded
1991
2013
Country
Canada
France
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
9.2B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
OTEX
ABVX
Price
$30.06
$116.47
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$39.00
$130.09
AVG Volume (30 Days)
752.5K
2.0M
Earning Date
02-05-2026
08-11-2025
Dividend Yield
3.64%
N/A
EPS Growth
10.23
N/A
EPS
1.91
N/A
Revenue
$5,187,535,000.00
$6,231,374.00
Revenue This Year
$2.76
$6.80
Revenue Next Year
$1.81
N/A
P/E Ratio
$15.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.79
$4.77
52 Week High
$39.90
$148.83

Technical Indicators

Market Signals
Indicator
OTEX
ABVX
Relative Strength Index (RSI) 27.76 45.11
Support Level $31.92 $113.40
Resistance Level $33.69 $130.13
Average True Range (ATR) 0.85 8.75
MACD -0.16 -1.95
Stochastic Oscillator 5.43 19.84

Price Performance

Historical Comparison
OTEX
ABVX

About OTEX Open Text Corporation

Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: